Lixisenatide/320367-13-3/刘经理18751911884微信同号

Lixisenatide 是胰高血糖素样肽 1 受体 (GLP-1R) 的激动剂，可用于ZL 2 型糖尿病
Description Lixisenatide is a glucagon-like peptide-1 (GLP-1) receptor agonist that can be used in the treatment of type 2 diabetes mellitus (T2DM). 
 
IC50 & Target GLP-1 receptor[1][2].
 
Clinical Trial  
Molecular Weight 4858.49 
 
Formula C₂₁₅H₃₄₇N₆₁O₆₅S
 
CAS No. 320367-13-3
 
Sequence His-Gly-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Leu-Ser-Lys-Gln-Met-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-Ile-Glu-Trp-Leu-Lys-Asn-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Ser-Lys-Lys-Lys-Lys-Lys-Lys-NH2
 
Sequence Shortening HGEGTFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPSKKKKKK-NH2
 
Shipping Room temperature in continental US; may vary elsewhere.
 
Storage Powder  -80°C 2 years 
  -20°C 1 year 
In solvent -80°C 6 months 
  -20°C 1 month 
 
制造商： 南京肽业生物科技有限公司
刘经理  18751911884 微信同号
QQ ： 467172867